JPRN-jRCT2011230051招募中1 期
ONO-4685-05 : An Open-label, Non-randomized, Phase I Dose Escalation Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in Patients With Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma(CLL/SLL)
Osawa Masahiro0 个研究点目标入组 108 人开始时间: 2023年11月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Patients with histopathologically confirmed diagnosis of one of the following subtypes as defined by the 2017 revision of the WHO classification of lymphoid malignancies:
- •Peripheral T-cell lymphoma(PTCL)
- •- Angioimmunoblastic T-cell lymphoma(AITL)
- •- Peripheral T-cell lymphoma, NOS(PTCL-NOS)
- •- Nodal peripheral T-cell lymphoma with TFH phenotype(nodal PTCL with TFH)
- •- Follicular T-cell lymphoma(FTCL)
- •Cutaneous T-cell lymphoma(CTCL)
- •- Mycosis fungoides(MF)
- •- Sezary syndrome
- •Chronic lymphocytic leukemia/small lymphocytic lymphoma(CLL/SLL)
- •2.Relapsed or refractory patients with tumors for which no established standard therapy is available, or refractory or intolerant to existing standard therapy
- •judged by principal investigatoror subinvestigator
- •3.ECOG PS 0~2
- •4.Life expectancy of at least 3 months
排除标准
- •1.Patients with severe complications.
- •2.Patients with multiple cancers.
研究者
相似试验
招募中
1 期
ONO-4578-02:ONO-4578 Phase 1 Studynresectable colorectal cancerJPRN-jRCT2031200215Hirashima Yoshinori36
进行中（未招募）
1 期
ONO-4578-06:Phase I study of ONO-4578 and letrozole plus CDK4 /6 inhibitors in breast cancerbreast cancerJPRN-jRCT2031210364Osawa Masahiro40
进行中（未招募）
1 期
ONO-4059-08:ONO-4059 phase 1Systemic SclerosisJPRN-jRCT2031200315Osawa Masahiro16
进行中（未招募）
1 期
ONO-7475-03 : ONO-7475 Phase 1 StudyEGFR mutated, stage IIIB/IIIC/IV or recurrent, NSCLC, which is unsuitable for radical irradiationJPRN-jRCT2051210045Osawa Masahiro75
招募中
1 期
ONO-4685-04: ONO-4685 Phase 1 studyAuto immune diseaseJPRN-jRCT2071220081Masahiro Osawa72